Cite
The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer
MLA
Andreas Hedblom, et al. “The Role of PI3K/AKT-Related PIP5K1α and the Discovery of Its Selective Inhibitor for Treatment of Advanced Prostate Cancer.” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 35, Jan. 2014, pp. E3689-98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....286d28c440ffc9bbeba29ec5de17a5cc&authtype=sso&custid=ns315887.
APA
Andreas Hedblom, Regina R. Miftakhova, Jenny L. Persson, Martuza Sarwar, Pirkko Härkönen, Liliya Shcherbina, Martin Johansson, Olov Sterner, Rikard Larsson, & Julius Semenas. (2014). The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 111(35), E3689-98.
Chicago
Andreas Hedblom, Regina R. Miftakhova, Jenny L. Persson, Martuza Sarwar, Pirkko Härkönen, Liliya Shcherbina, Martin Johansson, Olov Sterner, Rikard Larsson, and Julius Semenas. 2014. “The Role of PI3K/AKT-Related PIP5K1α and the Discovery of Its Selective Inhibitor for Treatment of Advanced Prostate Cancer.” Proceedings of the National Academy of Sciences of the United States of America 111 (35): E3689-98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....286d28c440ffc9bbeba29ec5de17a5cc&authtype=sso&custid=ns315887.